SPONSORS: United States of America, United Kingdom, Germany, Norway, United Arab Emirates
SIGNATORIES: China, Mexico, Austria, Australia
Measures to contain and combat the recent mutated malaria outbreak in North and Central America, Great Britain and France
The General Assembly,
Stressing its deep concern about the spread of infectious diseases due to climate change,
Noting with appreciation Mexico’s effort on developing a plan to reduce cases and eliminate transmission in targeted areas,
Recognizing the malaria case management as a vital component of the malaria control strategies, as well as the experience of the World Health Organization in tackling this issue and providing global, evidence-based recommendations on the case management of malaria, with regards to WHO Guidelines for the treatment of malaria, which were first published in 2006,
Taking into account the importance and effort of the World Health Organization of providing a framework for the development of specific and more detailed national treatment protocols that take into account local antimalarial drug resistance patterns and health service capacity in the country,
Deeply convinced a cooperative international reaction is necessary in dealing with the recent endemic outbreak of malaria in Mexico,
Noting the investment of the People’s Republic of China of 1 billion USD through the BRICS Healthcare Organization in the developing states of Asia, Africa and South America, bringing therefore the international community closer to solving the global healthcare crisis,
Endorsing all the financial and medical aid of the BRICS Health Organization aimed towards Africa, Asia and South America,
Alarmed by the possibilities of mutated malaria spreading to regions of highest risk, involving Sub-Saharan Africa, Papua New Guinea, Solomon Islands and Vanuatu,
Noting with appreciation the efforts made by the PATH Malaria Vaccines Initiative, Medicines for Malaria Venture, the International Vector Control Consortium, as well as the Foundation for Innovative New Diagnosis in order to combat this disease
Welcoming offers of aids from all countries interested in helping Mexico in treating and containing this outbreak,
1. Notes that necessary precautions should be taken into consideration by the international community, in order to combat further spreading of the disease,
2. Emphasizes the importance of the implementation of measures preventing mosquito bites, including:
a. Repellents, specifically:
i. DEET (N,N-diethyl-meta-toluamide)
ii. p-methane 3,8 diol (lemon eucalyptus)
iii. picaridin
iv. 3-ethlyaminopropionate
v. oil of citronella
b. Insecticides, specifically:
i. Permethrin,
ii. Other synthetic pyrethroids,
c. Insecticide-treated mosquito nets,
d. Clothing,
e. Room protection, with regards to:
i. air conditioning,
ii. ceiling fans,
iii. doors, windows-fine mesh netting,
3. Reiterates the role of the World Health Organization in order to provide efficient mechanisms for fighting malaria,
4. Calls upon the World Health Organization to continue its constructive efforts in the region,
5. Endorses the establishment of a Public Health Awareness campaign on malaria to facilitate the prevention of malaria in the region,
6. Recommends countries exercise restraint in their reaction to this outbreak in order to prevent panic,
7. Supports Mexico to close its borders, as well as staying in quarantine for as long as necessary,
8. Calls upon the United States of America, United Kingdom and France to quarantine its affected areas, raise awareness of this problem and prevent further spreading to other areas,
9. Welcomes all national, regional and international efforts aimed at ending the crisis, with regard to providing financial and medical aid to those in need,
10. Endorses all the financial and medical aid to endangered areas, including:
a. Mexico,
b. United States of America,
c. United Kingdom,
d. France,
11. Encourages the following health organizations to combat the issue of malaria disease in the coordinated regions:
a. National Institutes of Health, as well as the National Institute of Allergy and Infectious Diseases in the region of United States of America,
b. Northern Dimension Partnership in Public Health and Social Well-being (NDPHS), as well as the Regional Health Information Organization (RHIO) in Europe,
12. Advises for the government of the United States of America and Mexico to reestablish their border, as well as to maintain peace in the society without further alarms about the situation,
13. Calls upon Member States to inaugurate medical checks in the endangered areas in order to prevent ignorance from the disease, in accordance with the regional health organizations,
14. Emphasizes the importance of establishing secure health centers in order to treat the disease and prevent it from having severe consequences,
15. Strongly supports any national, regional and global initiative to support combating this issue, including:
a. Malaria No More UK,
b. Roll Back Malaria Partnership,
c. The Global Fund to Fight AIDS, Tuberculosis, and Malaria,
d. Imagine no Malaria,
e. Spread the Net,
16. Endorses the progress and effectiveness of indoor spraying with residual insecticides, it being effective 3-6 months, and supports the further development of its long-lasting forms,
17. Further instructs the establishment of protecting citizens and tourists with chemoprophylaxis with regards to the World Health Organization initiative, it suppressing the blood stage of malaria infections and thereby preventing it from occurring,
18. Emphasizes the importance of preventive treatments with sulfadoxine-pyrimethamine for pregnant women living in endangered areas,
19. Reiterates the necessity of developing a secure network and mechanism for salvaging and protecting areas with high risk of malaria:
a. Sub-Saharan Africa,
b. Papua new Guinea,
c. Solomon Islands,
d. Vanuatu,
20. Encourages the further development the PATH Malaria Vaccines Initiative, strategically using our resources to support and advance a range of vaccine approaches that target both humoral and cellular immunity, in accordance to the following organizations:
a. GlaxoSmithKline (GSK),
b. Johns Hopkins University (JHU),
c. International Centre for Genetic Engineering and Biotechnology (ICGEB),
d. Malaria Vaccine Development Program (MVDP),
e. National Institute of Allergy and Infectious Diseases (NIAID),
f. Naval Medical Research Center (NMRC),
g. New York University (NYU),
h. Oxford University (Oxford U),
i. University of Pennsylvania (UPenn),
j. Walter and Eliza Hall Institute (WEHI),
k. Walter Reed Army Institute of Research (WRAIR),
21. Decides to remain seized of the matter.